StockData
Compugen Ltd logo

Compugen Ltd (CGEN) income statement

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.84−0.04 (-2.13%)

Close on Nov 20, 2026Market cap $173.98MP/E 4.8Yield –

See a number that looks wrong?